{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:15:47Z","timestamp":1779164147054,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.euo.2018.05.006","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T22:02:29Z","timestamp":1528322549000},"page":"437-442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Pathological Outcomes for Patients Who Failed To Remain Under Active Surveillance for Low-risk Non\u2013muscle-invasive Bladder Cancer: Update and Results from the Bladder Cancer Italian Active Surveillance Project"],"prefix":"10.1016","volume":"1","author":[{"given":"Rodolfo","family":"Hurle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piergiuseppe","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Lazzeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Lughezzani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicol\u00f2 Maria","family":"Buffi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Saita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grazia Maria","family":"Elefante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Morenghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Forni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Cardone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuliana","family":"Lista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Maffei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Guazzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Casale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2018.05.006_bib0135","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0022-5347(05)67280-1","article-title":"Primary superficial bladder cancer risk groups according to progression, mortality and recurrence","volume":"164","author":"Millan-Rodriguez","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2018.05.006_bib0140","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.eururo.2013.08.034","article-title":"Long-term cancer-specific outcomes of TaG1 urothelial carcinoma of the bladder","volume":"65","author":"Rieken","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2018.05.006_bib0145","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol."},{"key":"10.1016\/j.euo.2018.05.006_bib0150","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0302-2838(02)00068-4","article-title":"Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies","volume":"41","author":"Brausi","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2018.05.006_bib0155","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/01.ju.0000076621.71247.6c","article-title":"Expectant management of small, recurrent, noninvasive papillary bladder tumours","volume":"170","author":"Soloway","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2018.05.006_bib0160","first-page":"567","article-title":"Is it necessary to always treat the relapses of superficial bladder tumour at the moment of diagnosis? Preliminary communication","volume":"29","author":"Martinez Caceres","year":"2005","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.euo.2018.05.006_bib0165","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.eururo.2005.12.029","article-title":"Watchful waiting policy in recurrent Ta G1 bladder tumours","volume":"49","author":"Gofrit","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2018.05.006_bib0170","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.juro.2007.08.171","article-title":"Conservative management of low risk superficial bladder tumours","volume":"179","author":"Pruthi","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2018.05.006_bib0175","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.urology.2008.12.061","article-title":"Safety of active surveillance program for recurrent non muscle-invasive bladder carcinoma","volume":"73","author":"Hernandez","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.euo.2018.05.006_bib0180","first-page":"132","article-title":"Active surveillance of low grade bladder tumors","volume":"80","author":"Gofrit","year":"2008","journal-title":"Arch Ital Urol Androl"},{"issue":"4 Suppl","key":"10.1016\/j.euo.2018.05.006_bib0185","first-page":"e731","article-title":"Oncological safety of an active surveillance program in recurrent non muscle-invasive bladder tumour","volume":"189","author":"de la Pena","year":"2013","journal-title":"J Urol"},{"issue":"4 Suppl","key":"10.1016\/j.euo.2018.05.006_bib0190","first-page":"e569","article-title":"Active surveillance in low risk bladder cancer. When TUR is recommended?","volume":"191","author":"Lozano","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2018.05.006_bib0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2015.11.005","article-title":"Long-term oncological outcomes of an active surveillance program in recurrent low grade Ta bladder cancer","volume":"34","author":"Hern\u00e1ndez","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2018.05.006_bib0200","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.juro.2017.08.091","article-title":"Active surveillance for low risk nonmuscle invasive bladder cancer: a confirmatory and resource consumption study from the BIAS project","volume":"199","author":"Hurle","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2018.05.006_bib0205","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/bju.13536","article-title":"Active surveillance for low-risk non-muscle-invasive bladder cancer: mid-term results from the Bladder cancer Italian Active Surveillance (BIAS) project","volume":"118","author":"Hurle","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2018.05.006_bib0210","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.urpr.2015.03.002","article-title":"A prospective study of size, number and histopathology of new and recurrent bladder tumors","volume":"2","author":"Strock","year":"2013","journal-title":"Urol Pract"},{"key":"10.1016\/j.euo.2018.05.006_bib0215","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0090-4295(95)96490-8","article-title":"Muscularis mucosa differentiates two populations with different prognosis in stage T1 bladder cancer","volume":"45","author":"Angulo","year":"1995","journal-title":"Urology"},{"key":"10.1016\/j.euo.2018.05.006_bib0220","series-title":"WHO classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs","year":"2004"},{"key":"10.1016\/j.euo.2018.05.006_bib0225","series-title":"AJCC cancer staging manual","year":"2009"},{"key":"10.1016\/j.euo.2018.05.006_bib0230","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1308\/rcsann.2016.0246","article-title":"Prediction of histological stage based on cystoscopic appearances of newly diagnosed bladder tumours","volume":"98","author":"During","year":"2016","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.euo.2018.05.006_bib0235","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1089\/end.2015.0591","article-title":"Detrusor muscle in TUR-derived bladder tumor specimens: can we actually improve the surgical quality?","volume":"30","author":"Capogrosso","year":"2016","journal-title":"J Endourol"},{"key":"10.1016\/j.euo.2018.05.006_bib0240","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1046\/j.1464-4096.2001.02396.x","article-title":"Does cystoscopy correlate with the histology of recurrent papillary tumours of the bladder?","volume":"88","author":"Herr","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2018.05.006_bib0245","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0302-2838(01)00035-5","article-title":"Prediction of muscle invasion of bladder cancer by cystoscopy","volume":"41","author":"Satoh","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2018.05.006_bib0250","first-page":"56","article-title":"Impact of a teaching program on outcome quality of white light transurethral resection for bladder tumor: a cohort study","volume":"2","author":"Hurle","year":"2016","journal-title":"J Solid Tumors"},{"key":"10.1016\/j.euo.2018.05.006_bib0255","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0022-5347(01)61778-6","article-title":"A prospective trial of flexible cystodiathermy for recurrent transitional cell carcinoma of the bladder","volume":"161","author":"Wedderburn","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2018.05.006_bib0260","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/bju.12216","article-title":"Outpatient laser ablation of non-muscle-invasive bladder cancer: is it safe, tolerable and cost-effective?","volume":"112","author":"Wong","year":"2013","journal-title":"BJU Int"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258893111830066X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258893111830066X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:44:19Z","timestamp":1762875859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258893111830066X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S258893111830066X"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2018.05.006","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathological Outcomes for Patients Who Failed To Remain Under Active Surveillance for Low-risk Non\u2013muscle-invasive Bladder Cancer: Update and Results from the Bladder Cancer Italian Active Surveillance Project","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2018.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}